Dr. Gul Konuklar Joins Vertosa as VP of R&D to Drive Innovation in Cannabis Technology
Vertosa Welcomes Dr. Gul Konuklar as VP of Research & Development
In an exciting development for the cannabis industry, Vertosa, a frontrunner in cannabis and hemp infusion technology, has appointed Dr. Gul Konuklar as its new Vice President of Research and Development. This strategic hiring underscores Vertosa's commitment to innovation and leadership in the market as they continue to expand their reach and enhance their product offerings.
Dr. Konuklar's Impressive Background
Dr. Konuklar brings to Vertosa a rich background in research and development, characterized by significant achievements in product development, plant design, and process optimization. Before her arrival at Vertosa, she held key roles that involved the design and execution of multiple pilot and commercial plants. Notably, she has successfully presented pioneering processes to the FDA, all of which received approval. Her impressive resume also boasts the creation of a Pac-Asia R&D laboratory and two material science labs, as well as holding 15 patents with many pending applications.
Her career highlights extend to extensive collaboration with the United States Department of Agriculture (USDA) and over 14 years at Abbott, where she honed her skills in a global healthcare setting. With this wealth of experience, Dr. Konuklar is poised to make impactful contributions to Vertosa's mission.
A Significant Milestone for Vertosa
Ben Larson, CEO of Vertosa, expressed enthusiasm about Dr. Konuklar's addition to the team. He remarked, "Dr. Konuklar's addition marks a pivotal moment in Vertosa's path to becoming the world leader in cannabis infusion technology. Her substantial record of innovation, coupled with her extensive professional experience, positions her well to help us create the most effective and trusted cannabis solutions out there."
Working alongside Dr. Harold Han, Co-Founder and Chief Science Officer at Vertosa, Dr. Konuklar will lead initiatives aimed at enhancing the company’s product offerings while also expanding their intellectual property portfolio. Dr. Han conveyed his confidence in Dr. Konuklar's ability to drive improvements across the company's quality systems and process engineering protocols. "Gul's profound expertise in R&D and her thoughtful product innovation will be crucial as we continue to challenge the limits of cannabis technology," he stated.
Looking Ahead
Dr. Konuklar expressed her excitement in joining Vertosa, highlighting her eagerness to collaborate with a team dedicated to pushing boundaries in cannabis infusion standards. "I am thrilled to contribute to a company that is redefining quality and innovation in the cannabis space," she commented, emphasizing her commitment to developing solutions that anticipate customer needs and deliver exceptional value.
About Vertosa
Founded with a mission to create industry-leading active ingredients, Vertosa specializes in crafting emulsion systems that can seamlessly integrate into any product. As a science-first company, Vertosa partners closely with its clients to provide comprehensive support in product development, utilizing patented technology to customize cannabinoid delivery. This ensures precision, stability, and increased bioavailability in their product lines.
As Dr. Konuklar assumes her new responsibilities, the industry watches closely, anticipating that her leadership will further solidify Vertosa's position at the forefront of cannabis innovation, paving the way for advancements that could shape the future of cannabis-infused products.